SeaSpine Holdings Corporation (NASDAQ: SPNE) and Orthofix International N.V. (NASDAQ:OFIX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, institutional ownership and earnings.

Volatility and Risk

SeaSpine Holdings Corporation has a beta of 0.11, meaning that its share price is 89% less volatile than the S&P 500. Comparatively, Orthofix International N.V. has a beta of 0.15, meaning that its share price is 85% less volatile than the S&P 500.

Profitability

This table compares SeaSpine Holdings Corporation and Orthofix International N.V.’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
SeaSpine Holdings Corporation -26.37% -31.68% -24.15%
Orthofix International N.V. 0.33% 10.26% 7.57%

Insider and Institutional Ownership

42.0% of SeaSpine Holdings Corporation shares are owned by institutional investors. Comparatively, 93.8% of Orthofix International N.V. shares are owned by institutional investors. 14.6% of SeaSpine Holdings Corporation shares are owned by company insiders. Comparatively, 5.6% of Orthofix International N.V. shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings for SeaSpine Holdings Corporation and Orthofix International N.V., as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaSpine Holdings Corporation 0 0 3 0 3.00
Orthofix International N.V. 0 0 5 0 3.00

SeaSpine Holdings Corporation presently has a consensus price target of $18.50, suggesting a potential upside of 77.20%. Orthofix International N.V. has a consensus price target of $53.30, suggesting a potential upside of 0.78%. Given SeaSpine Holdings Corporation’s higher possible upside, research analysts clearly believe SeaSpine Holdings Corporation is more favorable than Orthofix International N.V..

Earnings and Valuation

This table compares SeaSpine Holdings Corporation and Orthofix International N.V.’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio NetIncome Earnings Per Share Price/Earnings Ratio
SeaSpine Holdings Corporation $128.86 million 1.09 -$43.21 million ($2.92) -3.58
Orthofix International N.V. $409.79 million 2.35 $3.05 million $0.07 755.68

Orthofix International N.V. has higher revenue and earnings than SeaSpine Holdings Corporation. SeaSpine Holdings Corporation is trading at a lower price-to-earnings ratio than Orthofix International N.V., indicating that it is currently the more affordable of the two stocks.

Summary

Orthofix International N.V. beats SeaSpine Holdings Corporation on 10 of the 12 factors compared between the two stocks.

About SeaSpine Holdings Corporation

SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment. It has a portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures in the lumbar, thoracic and cervical spine. It offers a portfolio of orthobiologics and spinal fusion hardware products for the treatment of patients suffering from spinal and other orthopedic disorders. Its orthobiologics products consist of a range of bone graft substitutes that are designed to improve bone fusion rates following a range of orthopedic surgeries, including spine, hip and extremities procedures.

About Orthofix International N.V.

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim. The Biologics products include AlloQuent Structural Allografts, Trinity ELITE, Trinity Evolution and VersaShield. The Extremity Fixation products include Fixator, Eight-Plate Guided Growth System and Contours VPS Volar Plating System III. The Spine Fixation products include Hallmark Anterior Cervical Plate System, Ascent LE Posterior Occipital Cervico-Thoracic (POCT) System, Firebird Deformity Correction System, Phoenix Minimally Invasive Spinal Fixation System, Samba-Screw System, LONESTAR Cervical Stand Alone (CSA), SKYHAWK Lateral Interbody Fusion System & Lateral Plate System and CENTURION POCT System.

Receive News & Ratings for SeaSpine Holdings Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaSpine Holdings Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.